Читать книгу Assisted Reproduction Techniques - Группа авторов - Страница 118

1 1 Cho N, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda B. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research and Clinical Practice. 2018; 138:271.

2 2 Wallach EE, Diamond MP, Wentz AC, Cherrington AD. Alterations in carbohydrate metabolism as they apply to reproductive endocrinology. Fertility and Sterility. 1988; 50:387–97.

3 3 Moley KH, Vaughn WK, Diamond MP. Manifestations of diabetes mellitus on mouse preimplantation development: effect of elevated concentration of metabolic intermediates. Human Reproduction. 1994; 9:113–21.

4 4 Oehninger S, Hofmann GE, Kreiner D, Acosta AA, Muasher SJ. Gonadotropin stimulation for in vitro; fertilization and embryo transfer in insulin‐dependent diabetics: follicular response, oocyte quality, embryo development, and follicular environment. Fertility and Sterility. 1990; 53:741–3.

5 5 Dicker D, Ben‐Rafael Z, Ashkenazi J, Feldberg D. in vitro; fertilization and embryo transfer in well‐controlled, insulin‐dependent diabetics. Fertility and Sterility. 1992; 58:430–2.

6 6 Kapoor D, Aldred H, Clark S, Channer KS, Jones TH. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Diabetes Care. 2007; 30:911–7.

7 7 Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A, Dandona P. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. The Journal of Clinical Endocrinology & Metabolism. 2004; 89: 5462–8.

8 8 Fraser A, Lawlor DA. Long‐term health outcomes in offspring born to women with diabetes in pregnancy. Current Diabetes and Reproduction 2014; 14:489.

9 9 Inkster ME, Fahey TP, Donnan PT, Leese GP, Mires GJ, Murphy DJ. Poor glycated haemoglobin control and adverse pregnancy outcomes in type 1 and type 2 diabetes mellitus: systematic review of observational studies. BMC Pregnancy Childbirth 2006; 6:30

10 10 Shannon GD, Alberg C, Nacul L, Pashayan N. Preconception healthcare delivery at a population level: construction of public health models of preconception care. Maternal Child Health Journal 2014; 18: 512–1531.

11 11 Ray JG, O’Brien TE, Chan WS. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta‐analysis. Quarterly Journal of Medicine 2001; 94:435–44.

12 12 Mahmud M, Mazza D. Preconception care of women with diabetes: a review of current guideline recommendations. BMC Women’s Health. 2010; 10:5.doi: 10.1186/1472‐6874‐10‐5.

13 13 Dixon JB, Le Roux CW, Rubino F, Zimmet P. Bariatric surgery for type 2 diabetes. The Lancet. 2012; 379:2300–11.

14 14 Panunzi S, De Gaetano A, Carnicelli A, Mingrone G. Predictors of remission of diabetes mellitus in severely obese individuals undergoing bariatric surgery: do BMI or procedure choice matter? A meta‐analysis. Annals of Surgery. 2014; 261: 459–67.

15 15 Gosman GG, King WC, Schrope B, et al. Reproductive health of women electing bariatric surgery. Fertility and Sterility. 2010; 94:1426–1431.

16 16 American College of Obstetricians and Gynecologists. Bariatric Surgery and Pregnancy. Practice Bulletin 105. Obstetrics and Gynecology. 2009; 113:1405–13.

17 17 Germain A, Brunaud L. Visceral surgery and pregnancy. Journal of Visceral Surgery 2010; 147:e129–e135.

18 18 Bebber FE, Rizzolli J, Casagrande DS, et al. Pregnancy after bariatric surgery: 39 pregnancies follow‐up in a multidisciplinary team. Obes Surg. Sep 05, 2010 published online.

19 19 Massin N. New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF. Human Reproduction Update. 2017 Mar 1; 23(2):211–20.

20 20 Diaz‐Arjonilla M, Schwarcz M, Swerdloff RS, Wang C. Obesity, low testosterone levels and erectile dysfunction. International Journal of Impotence Research. 2009 Mar; 21(2):89.

21 21 Nieschlag E, Swerdloff R, Behre HM, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morley JE, Schulman C, Wang C, Weidner W. Investigation, treatment, and monitoring of late‐onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. Journal of Andrology. 2006 Mar 4; 27(2):135–7.

22 22 Kapoor D, Goodwin E, Channer KS, Jones TH. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. European Journal of Endocrinology. 2006 Jun 1; 154(6):899–906.

23 23 Stanworth RD, Kapoor D, Channer KS, Jones TH. Statin therapy is associated with lower total but not bioavailable or free testosterone in men with type 2 diabetes. Diabetes Care. 2009 Apr 1; 32(4):541–6.